Literature DB >> 562164

Initiation and elongation of polyribonucleotide chains on rat ventral-prostate chromatin transcribed by homologous ribonucleic acid polymerase B.

P Thomas, P Davies, K Griffiths.   

Abstract

The characteristics of initiation of RNA synthesis and the elongation of RNA chains on rat ventral-prostate chromatin by RNA polymerase B were investigated by two methods. 1. Initiation was carried out under low-salt conditions with three ribonucleoside triphosphates, and elongation was begun in the absence of reinitiation by the addition of the fourth ribonucleoside triphosphate and increasing the salt concentration. 2. Stable initiation complexes were formed by preincubation of enzyme with template at 37 degrees C, elongation was started by the addition of all four ribonucleoside triphosphates and reinitiation or spurious RNA synthesis was prevented by rifamycin AF/013. The latter method gave more reliable results. The dependence of those parameters on the androgenic status of the animal was studied. During the first 24h after castration, elongation was mainly affected, whereas after 72h a smaller number of initiation sites for RNA polymerase B on chromatin was evident. Considerable diurnal variations in the various parameters were observed. Changes in the relative concentrations of the chromatin-associated proteins were also observed after castration. In the rat ventral-prostate gland androgenic steroids may not only influence one stage of the transcriptional process, but may affect many factors involved in the control of gene expression.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 562164      PMCID: PMC1164994          DOI: 10.1042/bj1660189

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  POSSIBLE SYNTHESIS OF POLYRIBONUCLEOTIDES OF KNOWN BASE-TRIPLET SEQUENCES.

Authors:  R W MASTER
Journal:  Nature       Date:  1965-04-03       Impact factor: 49.962

2.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

3.  The influence of steroid-receptor complexes on the stages of transcription of target-tissue chromatin.

Authors:  P Davies; P Thomas; K Griffiths
Journal:  J Steroid Biochem       Date:  1976 Nov-Dec       Impact factor: 4.292

4.  Purification of a 3S cytosol androgen receptor from rat prostate that stimulates DNA-dependent RNA synthesis in vitro.

Authors:  A L Hu; R M Loor; T Y Wang
Journal:  Biochem Biophys Res Commun       Date:  1975-08-18       Impact factor: 3.575

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Effects of alpha-amanitin on the stimulation of prostatic ribonucleic acid polymerase by prostatic steroid-protein receptor complexes.

Authors:  P Davies; K Griffiths
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

7.  Further studies on the stimulation of prostatic ribonucleic acid polymerase by x-5 alpha-dihydrotestosterone-receptor complexes.

Authors:  P Davies; K Griffiths
Journal:  J Endocrinol       Date:  1974-08       Impact factor: 4.286

8.  Mammalian RNA polymerases I and II: independent diurnal variations in activity.

Authors:  S R Glasser; T C Spelsberg
Journal:  Biochem Biophys Res Commun       Date:  1972-05-26       Impact factor: 3.575

9.  RNA chain elongation on a chromatin template.

Authors:  A Solage; H Cedar
Journal:  Nucleic Acids Res       Date:  1976-09       Impact factor: 16.971

10.  Template properties of liver chromatin.

Authors:  K Marushige; J Bonner
Journal:  J Mol Biol       Date:  1966-01       Impact factor: 5.469

View more
  1 in total

1.  Androgenic regulation of elongation of polyribonucleotide chains on rat ventral-prostate chromatin.

Authors:  P Thomas; P Davies; K Griffiths
Journal:  Biochem J       Date:  1978-02-15       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.